Preliminary Final Report (App 4E) year ended 31.3.17
Filed with ASX · · 105 pages · English
ALS' next earnings callALS (ASX:ALQ) Q2 2027 Earnings Call · Nov 23, 2026 at 10:00 AM ESTRegister
Earlier from ALS
- ALS acquires Leochimica Laboratory in Italy
- Raj Naran to succeed Greg Kilmister as ALS CEO and MD
- ALS acquires TECAM Laboratory Group in Brazil
- ALS H1FY17 Result within Guidance
- Half Year Report (App 4D) ended 30 Sept 2016
Later from ALS
- ALS finalises two strategic acquisitions
- ALS Evaluating Asset Care Business
- ALS sells Oil and Gas Business
- Chairmans AGM Address (inc. First Half FY18 Guidance)
- Incoming CEOs AGM Address
Follow ALS into a list and get an email when it puts out news.
Follow ALS